Noninvasive diagnosis of bladder carcinoma by enzyme-linked immunosorbent assay detection of CD44 isoforms in exfoliated urothelia

Clinical Cancer Research

Volumn 6, Issue 6, 2000, Pages 2381-2392

  Woodman, Anthony C ^a   Goodison, Steve ^b   Drake, Marcus ^c   Noble, Jeremy ^c   Tarin, David ^b,d  

^a CRANFIELD UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CHURCHILL HOSPITAL   (United Kingdom)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN;

ARTICLE; BLADDER CARCINOMA; CANCER RECURRENCE; CONTROLLED STUDY; CORRELATION FUNCTION; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UROTHELIUM;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD44; BLOTTING, WESTERN; CARCINOMA; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, GENETIC; PROTEIN ISOFORMS; RECURRENCE; SENSITIVITY AND SPECIFICITY; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 0034122602     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Torti, F. M., Lum, B. L., Aston, D., MacKenzie, N., Faysel, M., Shortliffe, L. D., and Freiha, F. Superficial bladder cancer: the primacy of grade in the development of invasive disease. J. Clin. Oncol., 5: 125-130, 1987.
2. Raab, S. S., Slagel, D. D., Jensen, C. S., Teague, M. W., Savell, V. H., Ozkutlu, D., Lenel, J. C., and Cohen, M. B. Low-grade transitional cell carcinoma of the urinary bladder: application of select cytologic criteria to improve diagnostic accuracy. Mod. Pathol., 9: 225-232, 1996.
3. Dalchau, R., Kirkley, J., and Fabre, J. W. Monoclonal antibody to a human brain-granulocyte-T lymphocyte antigen is probably homologous to the W3/13 antigen of the rat. Eur. J. Immunol., 10: 745-750, 1980.
4. Jalkanen, S., Jalkanen, M., Bargatz, R., Tammi, M., and Butcher, E. C. Biochemical properties of glycoproteins involved in lymphocyte recognition of high venules in man. J. Immunol., 141: 1615-1623, 1987.
5. Lesley, J., Hyman, R., and Kincade, P. W. CD44, and its interaction with extracellular matrix. Adv. Immunol., 54: 271-335, 1993.
6. Rudzki, Z., and Jothy, S. CD44 and the adhesion of neoplastic cells. Mol. Pathol., 50: 57-71, 1997.
7. Lesley, J., and Hyman, R. CD44 structure, and Function. Front. Biosci., 3: D616-D630, 1998.
8. Gunthert, U., Hofmann, M., Rudy, W., Reber S., Zoller, U., Haussmann, I., Matzku, S., Wenzel, A., Ponta, H., and Herrlich, P. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell, 65: 13-14, 1991.
9. Rudy, W., Hofmann, M., Schwartz-Albiez, R., Zoller, M., Heider, K. H., Ponta, H., and Herrlich, P. The two major CD44 proteins expressed on a metastatic rat tumor cell line are derived from different splice variants: each one individually suffices to confer metastatic behavior. Cancer Res., 53: 1262-1268, 1993.
10. Heider K-H., Hofmann, M., Hors, E., van der Berg, F., Ponta, H., Herrlich, P., and Pals, S. T. A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. J. Cell Biol., 120: 227-233, 1993.
11. Matsumura, Y., and Tarin, D. Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet, 340: 1053-1058, 1993.
12. Tanabe, K. K., Ellis, L. M., and Saya, H. Expression of Cd44R1 adhesion molecule in colon carcinomas and metastasis. Lancet, 341: 725-726, 1993.
13. Matsumura, Y., Hanbury, D., Smith, J., and Tarin, D. Non-invasive detection of malignancy by identification of unusual CD44 gene activity in exfoliated cancer cells. Br. Med. J., 308: 619-624, 1994.
14. Dall, P., Heider K-H., Hekele, A., von Minckwitz, G., Kaufman, M., Ponta, H., and Herrlich, P. Surface protein expression and messenger RNA-splicing analysis of CD44 in uterine cervical cancer and normal cervical epithelium. Cancer Res., 54: 3337-3341, 1994.
15. Iida, N., and Bourguinon, L. Y. W. New CD44 splice variants associated with human breast cancers. J. Cell. Physiol., 162: 127-133, 1995.
16. Goodison, S., and Tarin, D. Current status of CD44 variant isoforms as cancer diagnostic markers. Histopathology (Oxf.), 32: 1-6, 1998.
17. Goodison, S., and Tarin, D. Clinical implications of anomalous CD44 gene expression in neoplasia. Front. Biosci., 3: E89-E109.
18. Naor, D., Sionov, R. V., and Ish-Shalom, D. CD44: structure, function and association with the malignant process. Adv. Cancer Res., 71: 241-319, 1997.
19. Sugiyama, M., Woodman, A. C., Sugino, T., Crowley, S., Ho, K., Smith, H., Matsumura, Y., and Tarin, D. Non-invasive detection of bladder cancer by identification of abnormal CD44 proteins in exfoliated cancer cells in urine. J. Clin. Pathol: Mol. Pathol., 48: M142-M147, 1995.
20. Borgya, A., Woodman, A. C., Sugiyama, M., Donie, F., Kopetski, E., Matsumura, Y., and Tarin, D. Isolation and characterisation of antibodies which specifically recognise the peptide encoded by exon 7 (v2) of the human CD44 gene. J. Clin. Pathol: Mol. Pathol., 48: M241-250, 1995.
21. Woodman, A. C., Sugiyama, M., Yoshida, K., Sugino, T., Borgya, A., Goodison, S., Matsumura, Y., and Tarin, D. Analysis of anomalous CD44 gene expression in human breast, bladder, and colon cancer and correlation of observed mRNA and protein isoforms. Am. J. Pathol., 749: 1519-1530, 1996.
22. Sugino, T., Gorham, H., Yoshida, K., Bolodeoku, J., Nargund, V., Cranston, D., Goodison, S., and Tarin, D. Progressive loss of CD44 gene expression in invasive bladder cancer. Am. J. Pathol., 149: 873-882, 1996.
23. Guo, Y. J., Liu, G., Wang, X., Jin, D., Wu, M., Ma, J., and Sy, M. S. Potential use of soluble CD44 in serum as indicator of tumor burden and metastasis in patients with gastric or colon cancer. Cancer Res., 54: 422-426, 1994.
24. Martin, S., Jansen, F., Bokelmann, J., and Kolb, H. Soluble CD44 splice variants in metastasizing human breast cancer. Int. J. Cancer, 74: 443-445, 1997.
25. Lackner, C., Moser, R., Bauernhofer, T., Wilders-Truschnig, M., Saminigg, H., Berghold, A., and Zatloukal, K. Soluble CD44 v5 and v6 in serum of patients with breast cancer. Correlation with expression of CD44 v5 and v6 variants in primary tumors and location of distant metastasis. Breast Cancer Res. Treat., 47: 29-40, 1998.
26. Darai, E., Leblanc, M., Walker-Combrouze, F., Brinuier, A. F., Madelenet, P., and Scoazec, J. Y. Expression of cadherins and CD44 isoforms in ovarian endometrial cysts. Hum. Reprod. (Oxf.), 13: 1346-1352, 1998.
27. Darai, E., Bringuier, A. F., Walker-Combrouze, F., Feldmann, G., Madelenet, P., and Scoazec, J. Y. Soluble adhesion molecules in serum and cyst fluid from patients with cystic tumours of the ovary. Hum. Reprod. (Oxf.), 13: 2831-2835, 1998.
28. Yoshida, K., Sugino, T., Tahara, H., Woodman, A. C., Bolodeoku, J., Nargund, V., Fellows, G., Goodison, S., Tahara, E., and Tarin, D. Telomerase activity in bladder carcinoma and its implication for noninvasive diagnosis by detection of exfoliated cancer cells in urine. Cancer (Phila.), 79: 362-369, 1997.
29. D'Hallewin, M. A., and Baert, L. Initial evaluation of the bladder tumor antigen test in superficial bladder cancer. J. Urol., 155: 475-476, 1996.
30. Schamhart, D. H., de Reijke, T. M., van der Poel, H. G., Witjes, J. A., de Boer, E. C., Kurth, K., and Schalken, J. A. The Bard BTA test: its mode of action, sensitivity and specificity, compared to cytology of voided urine, in the diagnosis of superficial bladder cancer. Eur. Urol., 34: 99-106, 1998.
31. Soloway, M. S., Briggman, V., Carpinito, G. A., Chodak, G. W., Church, P. A., Lamm, D. L., Lange, P., Messing, E., Pasciak, R. M., Reservitz, G. B., Rukstalis, D. B., Sarosdy, M. F., Stadler, W. M., Thiel, R. P., and Hayden, C. L. Use of a new tumor marker, urinary NMP22, in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment. J. Urol., 156: 363-367, 1996.
32. Serretta, V., Lo Presti, D., Vasile, P., Gange, E., Esposito, E., and Menozzi, I. Urinary NMP22 for the detection of recurrence after transurethral resection of transitional cell carcinoma of the bladder: experience on 137 patients. Urology, 52: 793-796, 1998.
33. Schmetter, B. S., Habicht, K. K., Lamm, D. L., Morales, A., Bander, N. H., Grossman, H. B., Hanna, M. G., Jr., Silberman, S. R., and Butman, B. T. A multicenter trial evaluation of the fibrin/fibrinogen degradation products test for detection and monitoring of bladder cancer. J. Urol., 158: 801-805, 1997.
34. Wiener, H. G., Mian, C., Haitel, A., Pycha, A., Schatzl, G., and Marberger, M. Can urine bound diagnostic tests replace cystoscopy in the management of bladder cancer? J. Urol., 159: 1876-1880, 1998.
35. Pode, D., Golijanin, D., Sherman, Y., Lebensart, P., and Shapiro, A. Immunostaining of Lewis X in cells from voided urine, cytopathology and ultrasound for noninvasive detection of bladder tumors. J. Urol., 159: 389-392, 1998.
36. Buchumensky, V., Klein, A., Zemer, R., Kessler, O. J., Zimlichman, S., and Nissenkorn, I. Cytokeratin 20. a new marker for early detection of bladder cell carcinoma? J. Urol., 160: 1971-1974, 1998.
37. Klein, A., Zemer, R., Buchumensky, V., Klaper, R., and Nissenkorn, I. Expression of cytokeratin 20 in urinary cytology of patients with bladder carcinoma. Cancer (Phila.), 82: 349-354, 1998.
38. Steiner, G., Schoenberg, M. P., Linn, J. F., Mao, L., and Sidransky, D. Detection of bladder cancer recurrence by microsatellite analysis of urine. Nat. Med., 3: 621-624, 1997.
39. Kinoshita, H., Ogawa, O., Kakehi, Y., Mishina, M., Mitsumori, K., Itoh, N., Yamada, H., Terachi, T., and Yoshida, O. Detection of telomerase activity in exfoliated cells in urine from patients with bladder cancer. J. Natl. Cancer Inst., 89: 724-730, 1997.
40. Kavaler, E., Landman, J., Chang, Y., Droller, M. J., and Liu, B. C. Detecting human bladder carcinoma cells in voided urine samples by assaying for the presence of telomerase activity. Cancer (Phila.), 82: 708-714, 1998.